VEGFA and retinopathy of prematurity: This study showed lower prevalence of myopia following IVB therapy compared to LPC therapy, and eyes with Zone II ROP are significantly less myopic compared with eyes with Zone I ROP.[8] Tan et al.[20] evaluated progress of refractive fault in children treated for severe ROP by anti-VEGF agents with a meta-analysis study.